One in three people will be diagnosed with cancer during their lifetime. The community of
cancer patients is growing, and several common cancers are becoming increasingly …

The decline in cognitive function and the prevalence of neurodegenerative disorders are
among the most serious threats to health in old age. The prevalence of dementia has …

Cognitive impairment is a core feature of schizophrenia, which is aggravated by
antipsychotics-induced metabolic disturbance and lacks effective pharmacologic treatments …

The objective of this study was to evaluate the relation of metformin with change in cognition
and brain pathology. During a mean of 8 years (SD= 5.5) of annual follow-up visits …

Most people are familiar with metformin as a diabetic treatment option. Different positive
benefits have been found for it, in addition to its anti-diabetes properties. Cognitive function …

Recently, several clinical trials have attempted to find evidence that supports the anticancer
use of metformin in breast cancer (BC) patients. The current study evaluates the anticancer …

Metformin is the safest and the most widely prescribed first-line therapy for managing
hyperglycemia due to different underlying causes, primarily type 2 diabetes mellitus. In …

Mounting evidence links obesity, metabolic dysfunction, mood, and cognition. Compromised
metabolic health and psychological functioning worsen clinical outcomes, diminish quality of …

Background The preclinical and clinical data regarding the efficacy of metformin as a pro-
cognitive and anti-depressant therapy is mixed. We conducted a systematic review and meta …

INTRODUCTION Cancer-related cognitive impairment (CRCI) is prevalent in cancer
survivors, and impairments affect daily living tasks and overall wellbeing. This review aimed …